Navigation Links
Mystery Surrounding Use Of Abortion Pill Yet To Be Resolved

Reports of the death of four Californian women due to the toxic shock syndrome following consumption of the abortion pill RU-486 (Mifeprex) has created much confusion // and controversy among members of the scientific community.

It has been confirmed by health officials that it is due to the toxins produced by the highly lethal bacteria - Clostridium sordellii. So far, there have been only 10 reports of the fatal infection, 8 of which were in women who had given birth to live infants. One other was associated with an abortion, and the remaining one was not associated with pregnancy at all. It is still unclear if something in the abortion pill that could have caused the tragedy by increasing the chances of the infection.

Identifying C. sordellii infection in women who have induced abortion is complicated owing to the fact that there is similarity between the symptoms in by the fact that early symptoms (abdominal cramping, nausea, vomiting) tend to be the same as those experienced normally.

The abortion pill was first approved for termination of early pregnancy (7 week duration or less) in the United States in the year 2000. Since then, more than 460,000 doses of the medication have been distributed.

If the four deaths were the only ones to have occurred after using the drug, probably it would indicate that women who use it for induced abortion face a higher risk of contracting the infection. This would be approximate to a 10 times higher than the risk associated with surgical abortions performed early in pregnancy.

The biggest mystery relating to the tragedy is the incidence of all four cases in a single state while the FDA confirms the uniform frequency of drug usage throughout California. The CDC is hoping to raise awareness about the potential risks with the new report.

In view of the above report, may be it is time for doctors to closely examine the potential risks of any medication prescribed and keep a watch over any specific symptoms that could be a sign of the impending mortality.


'"/>




Related medicine news :

1. Mystery behind Preeclampsia uncovered
2. Understanding The Mystery Behind Sleepless Nights
3. Mystery of nacrolepsy uncovered
4. Cholesterol Mystery Solved By Nobel Laureates
5. A Step Towards Unraveling The Schizophrenia And Depression Mystery
6. $2.4 Million Grant To Unravel The Mystery Of Language Recognition.
7. Mystery behind Brain activity during recalling events disentangled
8. Mystery over bird flu infection to Ms. Zhou – China’s 7th bird flu victm
9. Mystery Of The Placebo Effect, Yet To Be Solved
10. Dry Earwax Mystery Solved: Ear Wax Gene Identified
11. Mystery Behind The Déjà Vu Phenomenon Yet To Be Resolvd
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:7/24/2017)... ... July 24, 2017 , ... SignatureCare Emergency Center ... be awarded for the fall semester to a deserving student. Get your applications ... 2017 scholarship was awarded to Mariana Castillo who is a nursing student at Prairie ...
(Date:7/24/2017)... , ... July 24, 2017 , ... ... (MCPS) have partnered together for a unique opportunity that helps high school girls succeed ... “Removing Barriers, Creating Opportunities.” Horizon Goodwill will host over 20 high school ...
(Date:7/24/2017)... , ... July 24, 2017 , ... The International Essential ... life-altering neurological condition called essential tremor (ET). The seminar will take place on Saturday, ... Woods Blvd., Independence, OH. The program will run from 9 a.m. to 12 p.m., ...
(Date:7/24/2017)... ... July 24, 2017 , ... The Topricin Companies, ... awareness for Topricin’s revolutionary, natural, after-burn skin care product, Topricin After Burn Cream. ... of long term skin conditions, including cancer. In the short term, overexposure ...
(Date:7/24/2017)... ... July 24, 2017 , ... Puregraft, the global ... the issuance of United States Patent Number 9,695,398 (the '398 patent) and South ... The '398 and '324 patents cover methods and systems for optimizing fat grafts ...
Breaking Medicine News(10 mins):
(Date:7/24/2017)... -- Diplomat Pharmacy, Inc. (NYSE: DPLO ) announced ... operating results on Monday, August 7, 2017 after market ... p.m. ET. Shareholders ... of the conference call by dialing 877-201-0168 or 647-788-4901 ... 15 minutes prior to the call. A live webcast ...
(Date:7/21/2017)... RESEARCH TRIANGLE PARK, N.C. , July 21, 2017 ... ) announced today that it will report its second ... Thursday, July 27, 2017. ... July 27, 2017, at 9:00 a.m. Eastern Time.  The ... dialing 1-970-315-0533.  A rebroadcast of the teleconference will be ...
(Date:7/21/2017)... you know that PhRMA member companies invested $65.5 billion in research ... medicines, generics and the supply chain account for 14 percent of ... this (7 percent)? Or that the United States ... in high-growth biopharmaceutical startups? ... The biopharmaceutical industry accounts for ...
Breaking Medicine Technology: